Gilead Welcomes You to ID Week 2020 We are honored to join the leading voices in HIV as we gather virtually for ID Week 2020.

Id week 2020. Trooskin MD PhD Assistant Professor Division of Infectious Diseases and HIV Medicine Drexel University College of Medicine Philadelphia Pennsylvania. An Innovative Approach that Delivers Powerful Results in Virologically-Suppressed Patients. Save sessions and appointments to a personalized calendar Save time with exhibitor and product recommendations.

ViiV Events during ID Week TM 2020 During ID Week TM 2020 we supported a number of events for healthcare professionals to share and discuss our latest scientific breakthroughs. ID Week 2020 The virtual IDWeekTM 2020 congress took place from the 21 -25th October A Message from Lynn Baxter With a near constant focus on COVID-19 there has been heightened attention on the importance of infectious disease research. VBI Vaccines Inc.

Data Presented at ID Week 2020 Thursday 22 October 2020 Sarah Elton-Farr Head of Global Investor Relations. Identity Week is a conference and exhibition bringing together the brightest minds in the identity sector to promote innovation new thinking and more effective identity solutions. VBI Vaccines Presents Phase 3 Sci-B-Vac Data at ID Week 2020 Back to video Joanne Langley MD Professor of Pediatrics and Community Health and Epidemiology CIHR-GSK Chair in Pediatric Vaccinology Dalhousie University and Head of the Division of Infectious Disease IWK Health Centre and principal investigator of the PROTECT study delivered the poster presentation.

VBIV VBI a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines today announced the presentation of two abstracts featuring data from the Phase 3 program evaluating Sci-B-Vac the companys 3-antigen prophylactic hepatitis B HBV vaccine in e-poster presentations at ID Week. This activity has been designed to meet the educational needs of physicians physician assistants advanced practice nurses and other health care professionals involved in the care of patients with HCV infection. Check back soon for content you missed post-event updates as well as recommendations for future events you may be interested in.

VBIV VBI a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines today announced the presentation of two abstracts featuring data from the Phase 3 program evaluating Sci-B-Vac the companys 3-antigen prophylactic hepatitis B HBV vaccine in e-poster presentations at ID Week. Key areas of focus include secure physical credentials digital identity and advanced authentication technologies such as biometrics. ID Week is the joint annual meeting of the Infectious Diseases Society of America IDSA Society for Healthcare Epidemiology of America SHEA the HIV Medical Association HIVMA the Pediatric Infectious Diseases Society PIDS and the Society of Infectious Diseases Pharmacists SIDP.

For more than 30 years weve been working to help put an end to the HIV epidemic pursuing innovations in HIV treatment and prevention. IDWeek 2020 The registration for this event has passed.